Cargando…
Constitutive Androstane Receptor-Mediated Inhibition of Metformin on Phase II Metabolic Enzyme SULT2A1
BACKGROUND: Metformin, as a first-line treatment for diabetes, interacts with many protein kinases and transcription factors which affect the expression of downstream target genes governing drug metabolism. Sulfotransferase, SULT2A1, one phase II metabolic enzyme, sulfonates both xenobiotic and endo...
Autores principales: | Hu, Xiaowen, Li, Mengsiyu, Zhang, Chunxue, Pang, Shuguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902148/ https://www.ncbi.nlm.nih.gov/pubmed/33643408 http://dx.doi.org/10.1155/2021/8867218 |
Ejemplares similares
-
A Possible Mechanism of Metformin in Improving Insulin Resistance in Diabetic Rat Models
por: Li, Mengsiyu, et al.
Publicado: (2019) -
Metabolism-Disrupting Chemicals and the Constitutive Androstane Receptor CAR
por: Küblbeck, Jenni, et al.
Publicado: (2020) -
Signaling control of the constitutive androstane receptor (CAR)
por: Yang, Hui, et al.
Publicado: (2014) -
A Targeted in Vivo SILAC Approach
for Quantification of Drug Metabolism Enzymes: Regulation by the Constitutive
Androstane Receptor
por: MacLeod, A. Kenneth, et al.
Publicado: (2013) -
Dimorphic metabolic and endocrine disorders in mice lacking the constitutive androstane receptor
por: Lukowicz, Céline, et al.
Publicado: (2019)